Tavo Biotherapeutics
UEI: F6W7H78TK9B1
• CAGE: 81WF4
• DBA: OCULO THERAPY LLC
Overview
Awardee Type
Parent
Name
Tavo Biotherapeutics
Headquarters
Memphis, TN
United States
United States
Most Recent Award
Sept. 1, 2024
Calculating
Federal grant recipient
TAVO BIOTHERAPEUTICS, INC
dba OCULO THERAPY LLC
(UEI F6W7H78TK9B1, CAGE 81WF4)
is headquartered in Memphis TN.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in January 2013 and
federally registered in
February 2018.
Federal Award Analysis
Tavo Biotherapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
TAVO BIOTHERAPEUTICS, INC
DBA
OCULO THERAPY LLC
UEI
F6W7H78TK9B1
CAGE Code
81WF4
Primary NAICS
SBA Certifications
None
Self Certifications
Woman Owned Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 13, 2013
Initial Registration
Feb. 14, 2018
Last Registration
May 16, 2025
Registration Activation
May 16, 2025
Registration Expiration
May 14, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
TN
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No